Treatment of folate metabolism abnormalities in autism spectrum disorder
Trials reported onset over roughly 4 to 8 weeks rather than immediately, with semaglutide averaging 15 to 22 percent of baseline body weight at the 2.4 mg maintenance dose and tirzepatide averaging 20 to 25 percent as a dual GLP-1 and GIP agonist
Nature 575(7784):688692 Liu H et al (2021) SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-kappaB signaling
However, GLP-1 delivery can be slow, sometimes taking up to two weeks, and the weight-loss program itself is very basic
J Clin Invest 121:33313342 Finan B, Yang B, Ottaway N et al (2012) Targeted estrogen delivery reverses the metabolic syndrome
[DOI] [PMC free article] [PubMed] [Google Scholar] 42.Berra-Romani R, Avelino-Cruz JE, Raqeeb A, Della Corte A, Cinelli M, Montagnani S, Guerra G, Moccia F, Tanzi F